The Editor’s Roundtable: Revisiting the Role of Beta Blockers in Hypertension

r. Roberts has received honoraria for speaking from erck, Whitehouse Station, New Jersey; Schering Plough, enilworth, New Jersey; Pfizer, New York, New York; straZeneca, Wilmington, Delaware; and Novartis, Annanale, New Jersey. Dr. Black has received honoraria for peaking and consulting from Pfizer, Novartis, Bristol-Myrs Squibb, New York, New York; Sanofi-Aventis, Bridgeater, New Jersey; Forest, New York, New York; Boehrnger-Ingelheim, Ridgefield, Connecticut; Merck, Gilead, oster City, California; Myogen, and Intercure, Fort Lee, ew Jersey. Dr. Bakris has received honoraria for speaking nd consulting from AstraZeneca, Abbott, Abbott Park, llinois; Bristol-Myers Squibb/Sanofi-Aventis, GlaxoSmithline, Research Triange Park, North Carolina; Merck, Noartis, Lilly, Indianapolis, Indiana; Walgreens, and Myoen. He has received grants from the National Institutes of ealth, Abbott, Boehringer-Ingelheim, GlaxoSmithline, Novartis, and Myogen. Dr. Mason has received inestigator-initiated research grants and honoraria for speakng or consulting from sanofi-aventis, Bristol-Myers quibb, Pfizer, and Forest Laboratories. Dr. Giles has reeived honoraria for speaking and consulting from Boehrnger-Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, ovartis, Forest Laboratories, and Pfizer. He has received rant funding from Novartis and AstraZeneca. All other ndividuals in a position to control content disclosed no elevant financial relationships.